Author Guidelines
Preparation, structure, reporting standards, and mandatory declarations for manuscript submission
Policy Version: v1 • Last Updated: 11/1/2026
Executive Summary / Purpose
Comprehensive author instructions, structural specifications, reference standards, and mandatory declarations for manuscript submission.
1. General Editorial Principles
Manuscripts submitted to IJPCTT must represent original scientific work that has not been published previously and is not under consideration elsewhere. All submissions must conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
2. Manuscript Structure
Submissions must be organized in the following sequence:
- Title Page: Informative, concise title; full names, institutional affiliations, departments, countries, and ORCID identifiers for all authors; corresponding author contact email.
- Structured Abstract: Maximum 300 words structured as: Background, Methods, Results, and Conclusions.
- Keywords: 4 to 6 MeSH-compliant keywords separated by semicolons.
- Main Text:
- Introduction: Clear statement of the pharmacological problem and objective.
- Methods: Detailed methodology facilitating scientific reproducibility, ethics approvals, and statistical analyses.
- Results: Objective presentation of findings supported by high-resolution figures and tables.
- Discussion: Clinical and pharmacological significance, mechanisms, comparisons with literature, and study limitations.
- Conclusion: Evidence-based summary of therapeutic implications.
- Mandatory Declarations:
- Ethics approval and consent to participate.
- Consent for publication (clinical case reports).
- Availability of data and materials.
- Competing interests disclosure.
- Funding and sponsorship sources.
- Authors' contributions (CRediT taxonomy).
- Acknowledgments.
- AI tools usage disclosure.
- References: Vancouver reference format numbered consecutively in order of citation using square brackets [1, 2].
3. Reporting Guidelines Compliance
Authors are strongly advised to consult the EQUATOR Network for research design reporting checklists:
- CONSORT for randomized clinical trials.
- STRENDA for experimental enzyme and pharmacological assays.
- PRISMA for systematic reviews and meta-analyses.
- ARRIVE for in vivo animal experiments.
- CARE for clinical case studies.
4. Submission Checklist & Procedure
All manuscripts must be submitted online through the IJPCTT Submission Portal in PDF or Word format with blinded copies where appropriate. There are no fees for manuscript submission or peer review. The Article Processing Charge (APC) is ₹1,000 per accepted article, invoiced solely upon formal acceptance following peer review. Payment does not guarantee acceptance.